TransCode Therapeutics to conduct reverse stock split

seekingalpha2024-11-25
  • TransCode Therapeutics (NASDAQ:RNAZ) said it will conduct a 1-for-33 reverse stock split.
  • The split is intended to increase the per share trading price of the firm's stock to help the company satisfy the minimum bid price requirement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment